A device that is a naturally-occurring, accelerator- or reactor-produced radioactive isotope and intended to be permanently implanted into the body in order to deliver curative or palliative radiotherapy treatments. It is typically placed in the body by means
| Company | Devices | Share |
|---|---|---|
| Medi-Physics, Inc. | 160 | 41% |
| Theragenics Corporation | 97 | 25% |
| Boston Scientific Corporation | 35 | 9% |
| Best Medical International, Inc. | 30 | 8% |
| Bard Brachytherapy, Inc. | 20 | 5% |
| Riverpoint Medical, Llc | 18 | 5% |
| Gt Medical Technologies, Inc. | 11 | 3% |
| Isoaid, L.L.C. | 11 | 3% |
| Sirtex Medical Inc. | 3 | 1% |
| Civatech Oncology, Inc. | 2 | 1% |
Company = labeler of record on GUDID. 10 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| KXK | Source, brachytherapy, radionuclide | 147 |
| KXK | Source, Brachytherapy, Radionuclide | 145 |
| NAW | Microspheres Radionuclide | 77 |
| IWG | Seed, isotope, gold, titanium, platinum | 35 |
| NAW | Microspheres radionuclide | 35 |
| NEU | Marker, Radiographic, Implantable | 18 |
Use these as the dimensions to specify in a tender line.
387 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Manual brachytherapy source, permanent implant", from 10 companies. The largest labeler is Medi-Physics, Inc. with 41% of records.
KXK (Source, brachytherapy, radionuclide), KXK (Source, Brachytherapy, Radionuclide), NAW (Microspheres Radionuclide), IWG (Seed, isotope, gold, titanium, platinum)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add manual brachytherapy source, permanent implant to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.